Browse News

Found 5 articles

• TrialScope Supports Moderna for Diversity Enrollment in Moderna’s Phase 3 Study of its COVID-19 Vaccine

  1/27/2021

  Fulfilling a commitment to diversity and inclusion in the Phase 3 COVE Study of the Moderna COVID-19 Vaccine, Moderna enlisted the help of TrialScope, the global leader in clinical trial disclosure and transparency technology, for patient recruitment. Moderna utilized TrialScope Connect, an industry-first patient

• SubjectWell Begins International Expansion with presence in the United Kingdom, Ireland and South Africa

  1/9/2020

  The risk-free clinical trials marketplace meets the needs of international global pharmaceuticals and sponsors by expanding the patient pool for all studies

• SubjectWell Partners with Human API to Provide Free Patient Medical Record Retrieval for Clinical Trial Sites and Sponsors

  12/5/2019

  SubjectWell, the risk-free clinical trial marketplace, has partnered with data-sharing platform Human API to provide free medical record retrieval to clinical trial sites and sponsors.

• SubjectWell Raises $10M to Expand Its Risk-Free Patient Recruitment Marketplace

  6/18/2019

  SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced its $10 million in Series A funding led by Windham Venture Partners, with participation from previous investors Healthy Ventures and Geekdom Fund.

• Biden Cancer Initiative, Michael J. Fox Foundation for Parkinson's Research, Novartis and Others Support Bridging Clinical Research & Clinical Health Care Collaborative

  11/16/2017

  The event, which has three focus areas — regulatory, technology, and people and processes — will feature many prominent speakers.